|
|||||||||
CHAPTER 141-160. Chapter 161-180CHAPTER 141-160
A. Cow's milk and eggs B. Cow's milk and tree nuts C. Peanuts D. Tree nuts E. Seafood and eggs
A. Systemic lupus erythematosis—malar rash sparing nasolabial folds B. Discoid lupus—hyperkeratotic rash around the ears C. Kawasaki disease—vesicular rash D. Juvenile dermatomyositis (JDM)—Gottron papules and heliotrope rash E. Henoch-Schö nlein purpura—palpable purpura on extensor surfaces of lower extremities
A. Celecoxib B. Cyclophosphamide C. Methotrexate D. Sulfasalazine E. Azathioprine
A. Oropharynx B. Joints C. Skin D. Kidney E. Eyes
Chapter 161-180
A. Cefazolin is a 1st generation cephalosporin, commonly used in preoperative prophylaxis against skin infections B. The 2nd generation cephalosporins have additional gram-negative activity as compared with 1st generation cephalosporins C. Ceftriaxone has good CSF penetration, making it useful in suspected meningitis D. Of the 3rd-generation cephalosporins, only ceftazidime has activity against P. aeruginosa E. Cefepime has activity against P. aeruginosa and methicillin-resistant S. aureus
A. MRSA skin infections also resistant to clindamycin B. Vancomycin-resistant enterococcal infection (VRE) C. Highly resistant coagulase-negative Staphylococcus central line infection D. S. pneumoniae bacteremia, with resistance to penicillin and clindamycin E. All of the above
A. Staphylococcus aureus strains that produce exfoliatins B. Staphylococcus aureus strains that produce enterotoxins C. Group A streptococcal strains that produce pyrogenic exotoxins D. Human herpesvirus type 6 E. Parvovirus B19
|
|||||||||
|